Intel, Inspur, BGI and Alibaba Cloud Jointly Launched the GATK Chinese Association for Precision Medicine

BEIJING, June 27, 2017 /PRNewswire/ -- Intel's Bio IT Forum was held in Beijing, China. In the forum, the first four members, Intel, Inspur, BGI (Beijing Genomics Institute), and Alibaba Cloud jointly announced the launch of GATK Chinese Association for Precision Medicine.

Mr. Liu Jun, Inspur's General Manager of Artificial Intelligence and High Performance Computing, gave the keynote speech, "AI+HPC: Life and Medical Application Acceleration". In recognition of Inspur's outstanding contributions to precision medicine, Inspur won Intel's "Best Practices Award" for their Integrated Genomic Appliance. Industry top executives and experts such as: Yang Xu, Intel Vice-President and President of China Division; Professor Yu Jun, Chief Scientist of transcriptome research in China National Science and Technology Program; and Kate Voss, GATK representative from Broad Institute; attended the forum.

GATK is currently the most widely used genome analysis software and is developed by Broad Institute from the United States. The establishment of the GATK Chinese Association will accelerate the adoption and use of GATK tools among Chinese users for precision medicine and will be an important segment of Intel partnership program for precision medicine. Intel predicts that by 2020, with the merger between biodata and the medical industry, all precision medical procedures, from genome sequencing to medical analysis and medical regimen, can be completed in less than 24 hours.

Inspur already has an extensive suite of innovative products for precision medicine and application deployment experience. The Inspur Genomics Appliance is designed to run on Inspur servers, allowing integration of fundamental bioinformation read aligners such as Bowtie, Bwa, with other Second-Generation and Next-Generation sequencing tools, while also utilizing quality control data preprocessing software like Fastqc. Inspur's Genomics Appliance can perform data analysis for the entire genome and allow additional re-sequencing input with Second-Generation analyzers. Presently, Shanghai Children's Hospital has carried out many research projects into rare child diseases using Inspur Genomic Appliance. These projects rely on the Intel genome database embedded in the genome appliance to create a comprehensive hardware and software system solution for high-throughput sequencing, sequence analysis, and database genome computations, etc.

In full support of the new artificial intelligence applications development for the medical industry, Inspur has created a new complete artificial intelligence solution for the medical domain. This "complex platform" solution, is based on diverse and innovative hardware, powerful scheduling & management utilities, and advanced analysis software enhanced with a deep learning framework. It has the capability to ingest data from multiple sources at the front-end, and support smart applications at the back-end. Inspur is committed to provide leading computing power for artificial intelligence solutions and to promote inclusive technologies that will benefit all.

SOURCE Inspur Electronic Information Industry Co., Ltd